Mundipharma Partners With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan Post published:January 12, 2020 Post category:Biotechnology/Pharmaceuticals
Tyvyt (Sintilimab Injection) Combined with ALIMTA (Pemetrexed) and Platinum Met Predefined Primary Endpoint in Phase 3 ORIENT-11 Study as First-Line Therapy in Nonsquamous NSCLC Post published:January 12, 2020 Post category:Pharmaceuticals
